13G INITIAL ANNUAL FILING - RTRX

Company

Travere Therapeutics, Inc.

Filed

February 10, 2014

Accession Number

0000053417-14-000133

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →